Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

Aficamten Delivers Positive Results in SEQUOIA-HCM

News Daily News

Aficamten Delivers Positive Results in SEQUOIA-HCM

December 27, 2023

Reduced EF Evident in Some Elite Endurance Athletes

News Daily News

Reduced EF Evident in Some Elite Endurance Athletes

Michael O'Riordan

December 21, 2023

TCT 778: IASD Implantation Effects on Exercise Capacity and Cardiac Hemodynamics: A Meta-analysis

Presentation TCT 2023

TCT 778: IASD Implantation Effects on Exercise Capacity and Cardiac Hemodynamics: A Meta-analysis

Presenter: Ahmed Elkheshen

October 26, 2023

REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation

News Conference News HFSA 2023

REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation

October 11, 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

October 11, 2023

October 2023 News Roundup

News Opinion CV Team Dispatch

October 2023 News Roundup

October 01, 2023

Subclinical HFpEF Common in Patients Undergoing AF Ablation

News Daily News

Subclinical HFpEF Common in Patients Undergoing AF Ablation

September 08, 2023

ESC Cardiomyopathy Guidelines Span Range of Phenotypes

News Conference News ESC 2023

ESC Cardiomyopathy Guidelines Span Range of Phenotypes

Yael L. Maxwell

August 31, 2023

IV Iron in HF Misses (Again) in HEART-FID, but Meta-analysis Sees a Role

News Conference News ESC 2023

IV Iron in HF Misses (Again) in HEART-FID, but Meta-analysis Sees a Role

August 26, 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

August 25, 2023

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

News Conference News TVT 2023

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Michael O'Riordan

June 12, 2023

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

News Daily News

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

June 05, 2023

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

April 19, 2023

April 2023 News Roundup

News Opinion CV Team Dispatch

April 2023 News Roundup

April 01, 2023

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

News Daily News

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

March 27, 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

March 24, 2023

Meta-analysis Hints at Survival Benefit With LAP Monitoring in HFrEF

News Conference News THT 2023

Meta-analysis Hints at Survival Benefit With LAP Monitoring in HFrEF

March 22, 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

News Conference News THT 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

March 22, 2023

Physiological Modeling at Rest and Exercise of a Novel Right-to-Right Cardiac Shunt

Presentation THT 2023

Physiological Modeling at Rest and Exercise of a Novel Right-to-Right Cardiac Shunt

Presenter: Greg Lewis

March 22, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.